Literature DB >> 12543694

Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China.

Hui Wang1, Swathi Kelkar, Weiyuan Wu, Minjun Chen, John P Quinn.   

Abstract

The prevalence of extended-spectrum beta-lactamase-producing strains was demonstrated in 5 of 44 (11.4%) Escherichia coli, 17 of 43 (39.5%) Klebsiella pneumoniae, 3 of 50 (6.0%) Enterobacter cloacae, and 2 of 25 (8.0%) Citrobacter freundii strains at a teaching hospital in China. Nineteen of these 27 strains expressed CTX-M-3 beta-lactamase (pI 8.6). A subset of the clinical isolates expressing the CTX-M-3 enzyme, tested by pulsed-field gel electrophoresis, revealed multiple clones. Five isolates expressed a novel enzyme, SHV-43 (pI 8.0), which had two substitutions (Leu113Phe and Thr149Ser) compared with SHV-1.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12543694      PMCID： PMC151729          DOI： 10.1128/AAC.47.2.790-793.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  25 in total

1.  Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland.

Authors:  Anna Baraniak; Janusz Fiett; Agnieszka Sulikowska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Cloning and nucleotide sequencing of the gene encoding the beta-lactamase from Citrobacter diversus.

Authors:  M Perilli; N Franceschini; B Segatore; G Amicosante; A Oratore; C Duez; B Joris; J M Frère
Journal:  FEMS Microbiol Lett       Date:  1991-09-15       Impact factor: 2.742

3.  Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.

Authors:  J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

4.  Characterization of beta-lactamases in situ on polyacrylamide gels.

Authors:  C C Sanders; W E Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

5.  Evolution of plasmid-coded resistance to broad-spectrum cephalosporins.

Authors:  C Kliebe; B A Nies; J F Meyer; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

6.  Development of a sensitive and specific enzyme-linked immunosorbent assay for detecting and quantifying CMY-2 and SHV beta-lactamases.

Authors:  Andrea M Hujer; Malcolm G P Page; Marion S Helfand; Bethany Yeiser; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

7.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

8.  A new plasmidic cefotaximase in a clinical isolate of Escherichia coli.

Authors:  A Bauernfeind; H Grimm; S Schweighart
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

9.  Extended-spectrum beta-lactamases in clinical isolates of Enterobacter gergoviae and Escherichia coli in China.

Authors:  Y Cheng; M Chen
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

10.  Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.

Authors:  J P Quinn; D Miyashiro; D Sahm; R Flamm; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191
View more
  27 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.

Authors:  Karen Lolans; Thomas W Rice; L Silvia Munoz-Price; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.

Authors:  Maria Virginia Villegas; Karen Lolans; Adriana Correa; Carlos Jose Suarez; Jaime A Lopez; Marta Vallejo; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

4.  Widely distributed and predominant CTX-M extended-spectrum beta-lactamases in Amsterdam, The Netherlands.

Authors:  N al Naiemi; A Bart; M D de Jong; C M Vandenbroucke-Grauls; P J G M Rietra; Y J Debets-Ossenkopp; P C Wever; L Spanjaard; A J Bos; B Duim
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

5.  Emergence and dissemination of Enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with IncFII (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids.

Authors:  Angela Novais; Rafael Cantón; Raquel Moreira; Luísa Peixe; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

6.  CTX-M-3 and CTX-M-15 extended-spectrum beta-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria.

Authors:  Nadjia Ramdani-Bouguessa; Nuno Mendonça; Joana Leitão; Eugénia Ferreira; Mohamed Tazir; Manuela Caniça
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

7.  In117, an unusual In0-like class 1 integron containing CR1 and bla(CTX-M-2) and associated with a Tn21-like element.

Authors:  Aránzazu Valverde; Rafael Cantón; Juan Carlos Galán; Patrice Nordmann; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

8.  In memoriam: John P. Quinn, MD.

Authors:  Federico Perez; Cesar A Arias; Karen Bush; George L Drusano; Karen Lolans; L Silvia Munoz-Price; David P Nicolau; Anne Marie Queenan; Louis B Rice; John Segreti; David M Shlaes; Robert A Weinstein; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

9.  Optimal Piperacillin-Tazobactam Dosing Strategies against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae.

Authors:  Henrietta Abodakpi; Kai-Tai Chang; Song Gao; Ana María Sánchez-Díaz; Rafael Cantón; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

10.  Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period.

Authors:  Lukasz Naumiuk; Anna Baraniak; Marek Gniadkowski; Beata Krawczyk; Bartosz Rybak; Ewa Sadowy; Alfred Samet; Józef Kur
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.